SCHEMBL17620993

SCHEMBL17620993

Cc1ccc2c(c1)sc1nc(C(=O)O)cn12

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 3/20 0.51
PARP15 Q460N3 2/20 0.51
PARP14 Q460N5 2/20 0.51
TNKS2 Q9H2K2 2/20 0.51
PARP2 Q9UGN5 2/20 0.51
MAPT P10636 2/20 0.47
LMNA P02545 5/20 0.45
TNKS O95271 1/20 0.44
PARP1 P09874 1/20 0.44
TIPARP Q7Z3E1 1/20 0.44
PARP16 Q8N5Y8 1/20 0.44
PARP12 Q9H0J9 1/20 0.44
PARP11 Q9NR21 1/20 0.44
PARP4 Q9UKK3 1/20 0.44
PARP3 Q9Y6F1 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18561321 0.84 TNKS (0.52) PARP10PARP15PARP14TNKS2PARP2
SCHEMBL18747055 0.83 PARP10 (0.61) PARP10PARP15PARP14TNKS2PARP2
SCHEMBL17620816 0.83 CA12 (0.41) MAPTLMNARAB9ATP53
SCHEMBL17620982 0.83 PARP15 (0.51) PARP15TNKS2PARP2MAPTLMNA
SCHEMBL17621008 0.83 THRB (0.44) MAPTTP53
SCHEMBL2922938 0.83 MAPT (0.53) PARP10PARP15PARP14TNKS2PARP2
SCHEMBL17621014 0.82 RAB9A (0.41) MAPTLMNANPC1RAB9ATP53
SCHEMBL17621089 0.82 FLT3 (0.41) MAPTLMNANPC1RAB9ATP53
SCHEMBL17620857 0.82 TP53 (0.64) PARP10PARP15TNKS2PARP2MAPT
SCHEMBL17621066 0.82 THRB (0.43) MAPTLMNANPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2019-08-20 US claimed
US-20180282348-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2018-10-04 US claimed
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2019-08-20 US disclosed
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2019-08-20 US disclosed
US-20180282348-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2018-10-04 US disclosed
WO-2016042172-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2016-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180282348-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS S100B, S100P, S100A4 PARP10 4739/4885PARP15 4454/4885PARP14 4752/4885
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors S100B, S100P, S100A4 PARP10 4739/4885PARP15 4454/4885PARP14 4752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.